Affinity Asset Advisors »

Proqr Thrapeutics N V shs euro shares owned by Affinity Asset Advisors

Quarter-by-quarter ownership of Proqr Thrapeutics N V shs euro (PRQR) shares owned by Affinity Asset Advisors from 13F filings

Historical chart of Affinity Asset Advisors investment in Proqr Thrapeutics N V shs euro

Tip: Access up to 7 years of quarterly data

All positions including Proqr Thrapeutics N V shs euro held by Affinity Asset Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Proqr Thrapeutics N V shs euro by Affinity Asset Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $7.7M 3.6M 2.13
2025-06-30 $7.1M 3.5M 2.04
2025-03-31 $4.4M 3.3M 1.33
2024-12-31 $7.5M 2.8M 2.65

More positions owned by Affinity Asset Advisors

Insmed Com Par $.01 (INSM)
Verona Pharma Sponsored Ads (VRNA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Xenon Pharmaceuticals (XENE)
Madrigal Pharmaceuticals (MDGL)
Apogee Therapeutics (APGE)
Arcellx Common Stock (ACLX)
Alkermes SHS (ALKS)
Nuvalent Inc-a (NUVL)
Abivax Sa Sponsored Ads (ABVX)
Mineralys Therapeutics (MLYS)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Merus N V (MRUS)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Lexeo Therapeutics (LXEO)

View all positions for Affinity Asset Advisors

Top funds holding Proqr Thrapeutics N V shs euro

Adage Capital Partners GP
Privium Fund Management B.V.
Affinity Asset Advisors
Morgan Stanley
Standard Life Aberdeen
Sio Capital Management
Kynam Capital Management
DAFNA Capital Management
Siren
Arrowpoint Asset Management
Platinum Investment Mangement
M28 Capital Management
Ikarian Capital
Point72 Asset Management
Citadel Advisors

View all funds holding Proqr Thrapeutics N V shs euro